If you have ordered research peptides before, you will have noticed they almost never arrive as a liquid. Instead, the vial contains a small white to off-white "cake" or powder. That format is not a shortcut or a packaging choice. It is the result of a process called lyophilisation, better known as freeze-drying, and it is the standard way to keep peptides stable between manufacture and use.
What lyophilisation is
Lyophilisation removes water from a material without ever heating it into a liquid-to-vapour boil. It happens in three broad stages:
- Freezing. The peptide solution is cooled until the water forms ice and the peptide is locked in place.
- Primary drying. Under a strong vacuum and gentle warming, the ice sublimates, meaning it turns straight from solid to vapour and skips the liquid phase entirely. This removes most of the water.
- Secondary drying. The temperature is raised slightly to drive off the small amount of water still bound to the peptide, leaving a very low residual moisture level.
The result is a porous, lightweight solid that keeps the shape of the frozen mass, which is why you often see a small cake at the bottom of the vial.
Why peptides are freeze-dried
Peptides in water are vulnerable. Moisture allows several degradation pathways to proceed, including hydrolysis (breaking of peptide bonds), deamidation, oxidation, and aggregation. Warmth and light speed these processes up. By removing almost all the water, lyophilisation slows these reactions dramatically, so the peptide can be stored, shipped, and handled with far less degradation than a ready-made solution would allow.
It also makes logistics simpler. A dry powder is light, does not need to be kept as cold in transit as a solution, and can be dispensed into vials at accurate quantities.
What is in the vial besides the peptide?
Some lyophilised products include a bulking agent such as mannitol, which helps the powder form a stable, even cake. Others contain only the peptide. This is one reason a Certificate of Analysis is worth reading: it should tell you what the vial contains and how purity was measured, and it should not be assumed from the label alone.
Handling lyophilised material in the laboratory
Freeze-dried peptides are often hygroscopic, meaning they readily absorb moisture from the air. That is the very thing lyophilisation was meant to remove, so good handling is mostly about keeping it out:
- Let the vial reach room temperature before opening. Opening a cold vial pulls moisture out of the air and onto the powder.
- Keep it sealed, dark, and cold. General guidance for lyophilised peptides is storage at around −20°C, protected from light and moisture. Always defer to the storage advice on your Certificate of Analysis.
- Minimise time open. Close the vial promptly after use.
- Avoid repeated freeze-thaw cycles once any solution has been prepared, as each cycle can damage the peptide.
The takeaway
Lyophilisation is the reason research peptides can be supplied stable, accurately measured, and shippable at all. Understanding it helps you interpret what you receive, store it correctly, and ask better questions of any supplier.
All ASPeptides products are supplied strictly for in vitro laboratory research use only. They are not medicinal products and are not for human or veterinary use. For related guidance, see our page on reconstitution and storage and our article on how to read a peptide Certificate of Analysis.